Cervical Cancer: India Develops Its First Vaccine

The Serum Institute of India, the world's biggest vaccine maker, has developed the countrys first cervical cancer shot that will hit the market soon.



Cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020, according to the World Health Organization. About 90% of the new cases and deaths worldwide occurred in low- and middle-income countries that year.